Collectively, these findings indicate that more severe NASH and fibrosis are formed in the liver tissues of HFCS-fed diet SIRT2 KO mice, demonstrating an accelerating role of SIRT2 deficiency in the process of NAFLD-NASH progression. This evidence concerns the gene SIRT2 and metabolic dysfunction-associated steatotic liver disease.